How to Treat Refractory Polymyalgia Rheumatica

Patients with polymyalgia rheumatica (PMR) who had relapsed while tapering glucocorticoid therapy were more likely to achieve sustained remission at one year and have a lower glucocorticoid exposure if they were treated with sarilumab (Kevzara) plus a rapid, 14-week glucocorticoid taper than if they received placebo plus a standard, 52-week glucocorticoid taper. This is according...
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Biologics/DMARDs Conditions Drug Updates Other Rheumatic Conditions Research Rheum glucocorticoid resistant IL-6 IL-6 inhibitors PMR FocusRheum Polymyalgia Rheumatica Research Review sarilumab Source Type: research